DAFNA Capital Management as of Sept. 30, 2016
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 74 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Vitae Pharmaceuticals | 10.4 | $15M | 716k | 20.92 | |
Cynapsus Therapeutics | 6.4 | $9.2M | 230k | 40.08 | |
AtriCure (ATRC) | 5.8 | $8.4M | 529k | 15.82 | |
NxStage Medical | 4.2 | $6.0M | 239k | 24.99 | |
Tandem Diabetes Care | 3.9 | $5.5M | 724k | 7.66 | |
Alder Biopharmaceuticals | 3.8 | $5.4M | 165k | 32.77 | |
Galapagos Nv- (GLPG) | 3.0 | $4.3M | 66k | 64.66 | |
Xenon Pharmaceuticals (XENE) | 2.9 | $4.2M | 514k | 8.10 | |
Aerie Pharmaceuticals | 2.4 | $3.5M | 92k | 37.74 | |
Loxo Oncology | 2.4 | $3.4M | 130k | 26.18 | |
Dermira | 2.3 | $3.3M | 99k | 33.82 | |
Neurocrine Biosciences (NBIX) | 2.3 | $3.2M | 64k | 50.63 | |
Insulet Corporation (PODD) | 2.1 | $3.0M | 74k | 40.93 | |
Tesaro | 2.1 | $3.0M | 30k | 100.24 | |
Ardelyx (ARDX) | 2.0 | $2.8M | 219k | 12.94 | |
Beigene (BGNE) | 1.9 | $2.8M | 90k | 30.81 | |
Protagonist Therapeutics (PTGX) | 1.8 | $2.6M | 124k | 21.13 | |
Foamix Pharmaceuticals | 1.8 | $2.6M | 278k | 9.26 | |
Insulet Corp note 2.000% 6/1 | 1.7 | $2.5M | 2.3M | 1.10 | |
Applied Genetic Technol Corp C | 1.6 | $2.4M | 240k | 9.78 | |
Inotek Pharmaceuticals | 1.6 | $2.2M | 237k | 9.48 | |
Aeglea Biotherapeutics | 1.6 | $2.2M | 350k | 6.41 | |
Cara Therapeutics (CARA) | 1.6 | $2.2M | 267k | 8.35 | |
Ophthotech | 1.5 | $2.2M | 47k | 46.14 | |
Radius Health | 1.4 | $2.0M | 37k | 54.08 | |
Immunomedics | 1.3 | $1.8M | 567k | 3.25 | |
BioSpecifics Technologies | 1.3 | $1.8M | 40k | 45.66 | |
Cytokinetics (CYTK) | 1.2 | $1.7M | 182k | 9.18 | |
Derma Sciences | 1.1 | $1.7M | 354k | 4.67 | |
Spectranetics Corporation | 1.1 | $1.6M | 66k | 25.09 | |
Macrogenics (MGNX) | 1.1 | $1.6M | 54k | 29.91 | |
Uniqure Nv (QURE) | 1.1 | $1.6M | 204k | 7.65 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.1 | $1.5M | 2.5M | 0.61 | |
Achillion Pharmaceuticals | 1.1 | $1.5M | 187k | 8.10 | |
Synergy Pharmaceuticals | 1.1 | $1.5M | 275k | 5.51 | |
Biotelemetry | 1.0 | $1.5M | 80k | 18.58 | |
Regulus Therapeutics | 1.0 | $1.4M | 422k | 3.30 | |
Rigel Pharmaceuticals | 0.9 | $1.2M | 340k | 3.67 | |
Windtree Therapeutics | 0.9 | $1.2M | 481k | 2.56 | |
Eiger Biopharmaceuticals | 0.8 | $1.2M | 90k | 13.39 | |
Stereotaxis (STXS) | 0.8 | $1.2M | 1.4M | 0.87 | |
Novadaq Technologies | 0.8 | $1.2M | 102k | 11.57 | |
Johnson & Johnson (JNJ) | 0.8 | $1.1M | 9.4k | 118.09 | |
Zogenix | 0.6 | $909k | 80k | 11.43 | |
Exactech | 0.6 | $855k | 32k | 27.03 | |
Scynexis | 0.6 | $825k | 213k | 3.87 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.6 | $792k | 600k | 1.32 | |
Essa Pharma | 0.5 | $733k | 196k | 3.75 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.5 | $720k | 600k | 1.20 | |
Dicerna Pharmaceuticals | 0.5 | $702k | 119k | 5.88 | |
Concert Pharmaceuticals I equity | 0.5 | $677k | 67k | 10.11 | |
Cogentix Medical | 0.5 | $643k | 354k | 1.82 | |
Syneron Medical Ltd ord | 0.4 | $615k | 86k | 7.16 | |
Ascendis Pharma A S (ASND) | 0.4 | $618k | 31k | 20.10 | |
Masimo Corporation (MASI) | 0.4 | $595k | 10k | 59.50 | |
Innocoll Hldgs | 0.4 | $581k | 100k | 5.81 | |
Array BioPharma | 0.3 | $468k | 69k | 6.75 | |
Minerva Neurosciences | 0.3 | $467k | 33k | 14.11 | |
Bluebird Bio (BLUE) | 0.3 | $407k | 6.0k | 67.83 | |
Pieris Pharmaceuticals | 0.3 | $409k | 223k | 1.83 | |
Immune Design | 0.2 | $303k | 40k | 7.58 | |
Celyad Sa | 0.2 | $296k | 13k | 23.63 | |
Aquinox Pharmaceuticals | 0.2 | $267k | 20k | 13.35 | |
Neuroderm Ltd F | 0.2 | $267k | 14k | 18.51 | |
Neos Therapeutics | 0.2 | $256k | 39k | 6.59 | |
Dextera Surgical | 0.2 | $264k | 140k | 1.88 | |
Palatin Technologies | 0.1 | $162k | 257k | 0.63 | |
Avinger | 0.1 | $147k | 31k | 4.77 | |
Nivalis Therapeutics | 0.1 | $122k | 15k | 8.13 | |
Catalyst Biosciences | 0.1 | $86k | 71k | 1.21 | |
Genvec | 0.0 | $45k | 96k | 0.47 | |
Cel-sci | 0.0 | $40k | 128k | 0.31 | |
Check Cap Ltd w exp 02/28/202 | 0.0 | $29k | 51k | 0.57 | |
Enteromedics | 0.0 | $5.0k | 33k | 0.15 |